search icon

    Market Snapshot

    • S&P Futures

      4,285.75

    • Dow Futures

      33,941

    • Nasdaq Futures

      13,555.25

    blog search icon

    Timber Pharmaceuticals, Inc.

    (AMEX:TMBR)

    $0.11

    $-0.00

    -4.04%

    Timber Pharmaceuticals, Inc. Chart

    TMBR Stock Price Today

    Timber Pharmaceuticals, Inc. (TMBR) stock declined over -4.04% intraday to trade at $0.114 a share on AMEX. The stock opened with a loss of -8.80% at $0.125 and touched an intraday high of $0.128, falling -8.80% against the last close of $0.125. The stock went to a low of $0.12 during the session.

    Stock Snapshot

    $0.125

    Prev. Close

    8.39 Million

    Market Cap

    $0.12

    Day Low

    $0.125

    Open

    70.59 Million

    Number of Shares

    $0.128

    Day High

    -

    P/E ratio

    -0.27

    EPS (TTM)

    0.22

    Cash Flow per Share

    1.00

    Free Float in %

    -

    Book Value

    4,734,305

    Volume

    Timber Pharmaceuticals, Inc. Historical Data

    DateOpenHighLowCloseVolume
    2022-08-17$0.125$0.128$0.12$0.1199,924,836
    2022-08-16$0.125$0.128$0.12$0.12511,408,800
    2022-08-15$0.13$0.133$0.121$0.12923,657,800
    2022-08-12$0.134$0.148$0.129$0.13646,343,400
    2022-08-11$0.135$0.187$0.12$0.15187,709,000
    2022-08-10$0.11$0.114$0.103$0.10841,446,900
    2022-08-09$0.12$0.12$0.102$0.10448,413,600
    2022-08-08$0.106$0.109$0.101$0.10226,535,100
    2022-08-05$0.1$0.105$0.099$0.10347,775,400
    2022-08-04$0.101$0.11$0.09$0.096105,181,500

    Contact Details

    110 Allen Road
    Suite 401
    Basking Ridge, NJ 07920
    United States

    Webiste:TMBR

    973 314 9577

    Company Information

    Employees-

    Beta0.13

    Sales or Revenue928.98 Thousands

    5Y Sales Change54.7%

    Fiscal Year Ends2021-12-30

    SectorHealth Care

    IndustryPharmaceuticals

    About Company

    Timber Pharmaceuticals LLC, a clinical-stage biopharmaceutical company, engages in the development and commercialization of treatments for orphan dermatologic diseases. The company's lead product candidates include TMB-001, a patented topical formulation of isotretinoin that has completed Phase 2b clinical trial for the treatment of moderate to severe subtypes of CI, a group of rare genetic keratinization disorders; and TMB-002, a proprietary topical formulation of rapamycin, which is in Phase 2b clinical trial for the treatment of facial angiofibroma in tuberous sclerosis complex, a multisystem genetic disorder resulting in the growth of hamartomas in multiple organs. It is also involved in the development of TMB-003, a proprietary formulation of Sitaxsentan, which is a selective endothelin-A receptor antagonist that is in preclinical development for the treatment of sclerotic skin diseases. In addition, the company engages in the development of BPX-01, which is in Phase 3 topical minocycline for the treatment of inflammatory lesions of acne vulgaris; and BPX-04 that is a Phase 3 ready topical minocycline for the treatment of papulopustular rosacea. It has license agreement with AFT Pharmaceuticals Limited. The company was founded in 2019 and is headquartered in Basking Ridge, New Jersey.

    Frequently Asked Questions

    icon

    What is the current Timber Pharmaceuticals, Inc. (TMBR) stock price?

    Timber Pharmaceuticals, Inc. (AMEX: TMBR) stock price is $0.114 as of the last check on Wednesday, August 17. During the trading session, TMBR stock reached the peak price of $0.128 while $0.12 was the lowest point it dropped to.

    icon

    TMBR's industry and sector of operation?

    The AMEX listed TMBR is part of Pharmaceuticals industry that operates in the broader Health Care sector. Timber Pharmaceuticals LLC, a clinical-stage biopharmaceutical company, engages in the development and commercialization of treatments for orphan dermatologic diseases. The company's lead product candidates include TMB-001, a patented topical formulation of isotretinoin that has completed Phase 2b clinical trial for the treatment of moderate to severe subtypes of CI, a group of rare genetic keratinization disorders; and TMB-002, a proprietary topical formulation of rapamycin, which is in Phase 2b clinical trial for the treatment of facial angiofibroma in tuberous sclerosis complex, a multisystem genetic disorder resulting in the growth of hamartomas in multiple organs.

    icon

    Who are the executives of TMBR?

    Mr. Joseph Lucchese
    Exec. VP & CFO
    Mr. Zachary Rome
    Director
    Mr. John Koconis M.B.A.
    Chairman, CEO & Pres
    Mr. Joseph Lucchese
    Exec. VP, CFO, Treasurer & Sec.

    icon

    What is the TMBR stock price today?

    TMBR stock traded closed the last session at $0.119, which is -$0.004799999999999999 or -4.04040404040404% lower than its previous close of $0.125. TMBR's current trading price is 32% lower than its 52-week high of $1.12 where as its distance from 52-week low of 0.09% is -89.39%.

    icon

    How many employees does TMBR have?

    Number of TMBR employees currently stands at -. TMBR operates from 110 Allen Road, Suite 401, Basking Ridge, NJ 07920, United States.

    icon

    Link for TMBR official website?

    Official Webiste of $TMBR is: https://www.timberpharma.com

    icon

    How do I contact TMBR?

    TMBR could be contacted at TMBR operates from 110 Allen Road, Suite 401, Basking Ridge, NJ 07920, United States, or at phone #973 314 9577 and can also be accessed through its website.

    icon

    How many shares of TMBR are traded daily?

    TMBR stock volume for the day was 4,734,305 shares while in the previous session number of TMBR shares traded was 9,924,836 . The average number of TMBR shares traded daily for last 3 months was 9.97 Million.

    icon

    How much did TMBR change today?

    The percentage change in TMBR stock occurred in the recent session was -4.04040404040404% while the dollar amount for the price change in TMBR stock was -$0.004799999999999999.

    icon

    What price range TMBR stock been trading in?

    In the recent session, the day high for TMBR stock was $0.128 while the low for TMBR stock touched on the day was $0.12.

    icon

    What is the market cap of TMBR currently?

    The market value of TMBR currently stands at 8.39 Million with its latest stock price at $0.114 and 70.59 Million of its shares outstanding.